These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4063806)

  • 1. Arecoline-induced elevations of regional cerebral metabolism in the conscious rat.
    Soncrant TT; Holloway HW; Rapoport SI
    Brain Res; 1985 Nov; 347(2):205-16. PubMed ID: 4063806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional brain metabolic responsivity to the muscarinic cholinergic agonist arecoline is similar in young and aged Fischer-344 rats.
    Soncrant TT; Holloway HW; Greig NH; Rapoport SI
    Brain Res; 1989 May; 487(2):255-66. PubMed ID: 2731046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acute and chronic arecoline treatment on cerebral metabolism and blood flow in the conscious rat.
    Maiese K; Holloway HH; Larson DM; Soncrant TT
    Brain Res; 1994 Mar; 641(1):65-75. PubMed ID: 8019853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methiothepin reduces glucose utilization in forebrain regions of awake rats.
    Ricchieri GL; Soncrant TT; Holloway HW; Rapoport SI
    Psychopharmacology (Berl); 1987; 93(4):449-56. PubMed ID: 3124178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone fails to alter local cerebral glucose utilization in the rat.
    Fanelli RJ; Walovitch RC; Jasinski DR; London ED
    Pharmacol Biochem Behav; 1988 Oct; 31(2):481-5. PubMed ID: 3244723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of isoflurane anesthesia on local cerebral glucose utilization in the rat.
    Ori C; Dam M; Pizzolato G; Battistin L; Giron G
    Anesthesiology; 1986 Aug; 65(2):152-6. PubMed ID: 3740504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute administration of ethanol on cerebral glucose utilization in adult alcohol-preferring and alcohol-nonpreferring rats.
    Strother WN; McBride WJ; Lumeng L; Li TK
    Alcohol; 2005 Feb; 35(2):119-28. PubMed ID: 15963425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oxotremorine on local glucose utilization in the rat cerebral cortex.
    Dam M; Wamsley JK; Rapoport SI; London ED
    J Neurosci; 1982 Aug; 2(8):1072-8. PubMed ID: 7108584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1994 Jul; 651(1-2):27-36. PubMed ID: 7922575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential metabolic activation of subcortical brain areas by acute administration of nicotine to rats.
    McNamara D; Larson DM; Rapoport SI; Soncrant TT
    J Cereb Blood Flow Metab; 1990 Jan; 10(1):48-56. PubMed ID: 2298836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-course and regional distribution of the metabolic effects of bromocriptine in the rat brain.
    Pizzolato G; Soncrant TT; Rapoport SI
    Brain Res; 1985 Aug; 341(2):303-12. PubMed ID: 4041797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral glucose utilization in rats is not altered by hindlimb restraint or by femoral artery and vein cannulation.
    Soncrant TT; Holloway HW; Stipetic M; Rapoport SI
    J Cereb Blood Flow Metab; 1988 Oct; 8(5):720-6. PubMed ID: 3417799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nicotine on local cerebral glucose utilization in the rat.
    London ED; Connolly RJ; Szikszay M; Wamsley JK; Dam M
    J Neurosci; 1988 Oct; 8(10):3920-8. PubMed ID: 3193185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the performance of schedule-induced polydipsia (SIP) in rats after arecoline and amphetamine treatments.
    Shen TF; Wang HC; Wan FJ; Tung CS
    Proc Natl Sci Counc Repub China B; 2001 Oct; 25(4):214-22. PubMed ID: 11699569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-dergocrine, cerebral glucose utilization and maze performance in middle-aged rats.
    Walovitch RC; Ingram DK; Spangler EL; London ED
    Pharmacol Biochem Behav; 1987 Jan; 26(1):95-101. PubMed ID: 3562504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscimol-scopolamine interactions in the rat brain: a study with 2-deoxy-D-[1-14C]glucose.
    Helén P; London ED
    J Neurosci; 1984 Jun; 4(6):1405-13. PubMed ID: 6726339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local cerebral glucose utilization in the symptomatic thiamine-deficient rat: increases in fornix and pyramidal tract.
    Sharp FR; Evans K; Bolger E
    Neurology; 1982 Aug; 32(8):808-14. PubMed ID: 7201576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in local cerebral glucose utilization induced by phencyclidine.
    Weissman AD; Dam M; London ED
    Brain Res; 1987 Dec; 435(1-2):29-40. PubMed ID: 3427457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo brain incorporation of [1-14C]arachidonate in awake rats, with or without cholinergic stimulation, following unilateral lesioning of nucleus basalis magnocellularis.
    Nariai T; DeGeorge JJ; Lamour Y; Rapoport SI
    Brain Res; 1991 Sep; 559(1):1-9. PubMed ID: 1723641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1996 Sep; 735(1):67-82. PubMed ID: 8905171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.